Brief: Painreform Completes Enrollment In The Second Part Of Its Phase 3 Bunionectomy Trial For PRF-110
26/06/2024 13:13
June 26 (Reuters) - PainReform Ltd PRFX.O :
* PAINREFORM COMPLETES ENROLLMENT IN THE SECOND PART OF ITS
PHASE
3 BUNIONECTOMY TRIAL FOR PRF-110
* PAINREFORM LTD: ANTICIPATES REPORTING TOP-LINE RESULTS
FROM
PHASE 3 TRIAL IN SECOND HALF OF 2024
Source text for Eikon: ID:nGNX7j7850
Further company coverage: PRFX.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on PRF Technologies
See all newsBrief: Prf Technologies S.H.N. Financial Investments Seeks Special General Meeting At Prf Technologies To Remove Directors, Appoint Three S.H.N. Nominees
U.S. STOCKS ON THE MOVE-Bumble, Tempus AI, TD Synnex
U.S. STOCKS ON THE MOVE-Bio-Techne, IBM, Apple
PRF Technologies rises as animal study shows pain drug matches approved rival
U.S. STOCKS ON THE MOVE-Wendy's, Canadian Solar, Bio-Techne